AllCells

Are you looking for ways to streamline your workflow while saving time and resources?

Great news – AllCells’ bulk cell isolation services is the perfect solution! Our expert team can make your lab operations more cost-effective, efficient, and reliable by taking care of the time- and labor-intensive cell isolations while you focus on what truly matters in your research.

Benefits include:

• Optimized positive and negative MACS process provides consistent, high-quality bulk cell isolations of important cell types.
• Get CD34+ HSPCs, T Cells, NK Cells, B Cells, Monocytes, and PBMCs from high-quality leukapheresis material collected from qualified donors in our extensive and diverse network.
• Create single-donor cell banks from bulk cell isolations to save time and achieve experimental consistency and comparability.

Learn more here:

Custom Cell Isolation Services | AllCells AllCells offers consistent, high-quality bulk cell isolations—both positive and negative separation are available—of important cell types from leukapheresis material collected from qualified donors in our extensive network.

Elevate your cell and gene therapy programs to new heights during AllCells’ Year-End Special Event. Save 25% on all Cord Blood CD34+ Cells from single or mixed donors through the end of the year.

Plan early and stock your freezers now for your upcoming projects and maximize the impact of your budget. Learn more: https://pages.allcells.com/allcells-year-end-promos-2023

AllCells' Year-End Special Event is here! Get a head start and maximize your 2023 budget with exclusive discounts on popular products, including RUO Cryopreserved Solo Leukopaks.

Save 25% Off List Price on MTS RUO Cryopreserved Solo Leukopaks until Dec 31, 2023 (promo code CRYOLP25). Plus, when you buy 3 or more, get an additional 20% Off List Price on GMP MTS Cryopreserved Leukopaks for a whole year!

Don't wait, our MTS products are in high demand and supplies are limited. Stock up now and make every research dollar count.

https://pages.allcells.com/allcells-year-end-promos-2023?utm_source=LinkedIn&utm_medium=Organic+Social&utm_campaign=Q3+23+-+CGT+EOY+Campaign+-+Wave+1

AllCells' Year-End Promotions Don't let your 2023 budget go unused – maximize its potential before it's too late!  Seize the opportunity to get a head start with AllCells' Year-End Special Event! For a limited time, we’re offering exclusive discounts on our most popular made-to-stock (MTS) products from now until the end of...

AllCells is committed to helping propel scientific advancements in CAR-T cell therapies and other immunotherapies that are transforming the landscape of pediatric cancer treatment.

Children like Emily Whitehead are living proof of the incredible impact of cancer research. As the first pediatric patient in the world to receive CAR T-cell therapy in 2012, Emily is now more than 10 years cancer free—a true success story. Emily’s journey inspired the Emily Whitehead Foundation devoted to helping more families by funding cutting-edge pediatric cancer research to create a brighter and healthier future for children battling cancer.

Let’s together.

Maximize your budget and experimental impact with our new RUO Quarter Leukopak format. You'll still get the total nucleated cells (TNCs) you need with better cost-efficiency and experimental flexibility without compromising on quality. Find out how you can do more with less: https://allcells.com/research-grade-tissue-products/leukopak/ #:~:text=5M-,Request,-a%20quote%20for

Leukemia and lymphoma are among the most prevalent blood cancers impacting people globally. Together with American Association for Cancer Research, we want to recognize Leukemia and Lymphoma Awareness Month to highlight the importance of research in propelling advancements that will make a difference in patient’s lives. AllCells is dedicated to supporting scientists worldwide who are on the front line of uncovering groundbreaking treatments like CAR-T cell therapies which are transforming the standard of care for patients.

There is still time to visit AllCells at Booth 100/101 during the at the Boston Hynes Convention Center.

Here are a few snaps at the summit, and a great speaking session presented by Yuki Kato Maves, PhD, AllCells’ Associate Director, Product Management.

Will you be attending the CAR-TCR Summit next week? On Day 1 August 30th at 11:30am, @ Yuki Maves, Associate Director, Product Management, will present in the Manufacturing track in Room 207 and discuss how healthy donor materials catalyze market approval and drive sustainable manufacturing of allogeneic CGT.

Check out Allcells CAR-TCR agenda: https://allcells.com/events/car-tcr-summit-2023/ #:~:text=Improving%20patient%20access

Schedule a meeting with our team: https://allcells.com/events/car-tcr-summit-2023/ #:~:text=REGISTER%20TODAY-,Schedule%20a%20Meeting,-VIEW%20ALL%20EVENTS

In case you missed it! Our expert, Stephanie Burks, AllCells’ Senior Product Manager, provided a unique industry perspective and highlight our innovative CD34+ solutions that can revolutionize your projects. Find out how Allcells’ expertise can aid in donor selection for a variety of programs, empowering you to fast-track your biomedical research.

Watch the on-demand replay: https://pages.allcells.com/mobilized_leukopaks_webinar

Partnering with a reliable supplier can significantly minimize the risk of having to switch suppliers down the line. AllCells sources our leukopaks from a diverse pool of eligible and IRB-consented healthy donors, providing a wide range of genetic backgrounds and comprehensive data for your studies.

Our quality management system adheres strictly to FDA and European Directive guidelines, ensuring the highest standards of quality and safety. Additionally, our pre-characterized donor selection program provides comprehensive data of donors and MNCs available for purchase. Learn more about our GMP leukopaks here: https://allcells.com/gmp/leukopak-gmp/

Whether you require fresh or cryopreserved leukopaks, standard or customized, AllCells has you covered. Speak with us today!

Introducing AllCells’ new Pre-Characterized Donor Selection Program – simplifying the process of screening, selecting, and collecting from GMP donors.

Unlock the potential of cryopreserved MNCs from GMP donors with comprehensive annotations, including:
- Donor attributes
- HLA (human leukocyte antigen) typing
- KIR (killer cell immunoglobulin-like receptor) typing
- Immunophenotyping

Download the one sheet to learn more: https://pages.allcells.com/pre-characterizeddonorprogram-onesheet?utm_source=LinkedIn&utm_medium=Social+Post&utm_campaign=Q2+23+-+Pre-Characterized+Donor+Selection+Program+Launch

Our latest blog post is now live! Discover the insights shared by Lauren Greene, AllCells’ VP of Donor Operations, at the Allogeneic Cell Therapies Summit conference.

Learn why we need to reframe the donor paradigm to meet the imminent manufacturing boom and ensure the future sustainability of cell and gene therapies.
Read more here: https://lnkd.in/gQ2kkMS8

Turn your research into groundbreaking discoveries using our high-quality Cord Blood CD34+ cells. For a limited time only, we're offering an exclusive 20% discount on inventory lots of cryopreserved CD34+ cells isolated from single or mixed cord blood units (terms and conditions apply).

Don't miss out on this opportunity to optimize your workflow and enhance the quality of your research. Place your order today and get started!

https://pages.allcells.com/cd34-cord-blood-discount-2023

Limited Time CD34+ Cord Blood Discount Take advantage of our limited time offer and save 20% off list price on both Single and Mixed Cord Blood CD34+ cells.

Bonjour to all our colleagues in Paris attending ISCT! We are excited to meet with you to discuss your research and how AllCells can support your GMP and RUO primary cell needs.

Click the link below to schedule a meeting with our CGT experts or stop by Booth #35 to connect with us at the show. À bientôt!

https://allcells.com/events/isct-2023/

We hope you enjoyed Lauren Greene’s, VP of Donor Operations, presentation about “Reframing the Inherent Donor Supply Chain Ecosystem to Support the Imminent CGT Manufacturing Boom.”

Couldn’t make it to the plenary session? Stop by our booth to learn more about how donor supply impacts your CGT projects and about AllCells’ current promotions to support your CGT primary cell needs.

AllCells will be at ISCT in Paris, May 31st to June 3rd! Our GMP and RUO portfolios are now widely accessible in Europe, and we look forward to learning how to best serve your CGT needs.

Connect with our team at Booth #35 or click the link below to schedule a meeting with one of our CGT experts!

https://allcells.com/events/isct-2023/

Are you attending the upcoming Allogeneic Cell Therapies Summit? Be sure to join Lauren Greene (VP, Donor Operations) for her plenary session on May 23rd at 10 am. She’ll be talking about “Reframing the Inherent Donor Supply Chain Ecosystem to Support the Imminent CGT Manufacturing Boom”.

We hope you can join us for this discussion, which is currently top-of-mind for many CGT developers. It will be an excellent opportunity to gain valuable insights and a unique industry perspective from our experts.